Calithera is developing first-in-class small molecule drugs that slow tumor growth through controlling key metabolic pathways in the tumor and immune cells.
... investor relations and other expenses associated with being a public company. Personnel costs consist of salaries, benefits and stock-based compensation.
Annual Report and Financial Statements for the ... Strong market conditions in the first nine months of the year enabled Cala to sell out for 2022 in September, ...
Missing: investor relations
People also ask
What happened to Calithera Biosciences?
The Personal Relations and Fundraising Committee (PR&F Committee) of the Chinese American Librarians Association (CALA) is commemorating CALA's 50th anniversary ...
Missing: investor | Show results with:investor
Get the latest insights on Calithera Biosciences Inc. (CALA) with press releases and corporate news to help you in your trading and investing decisions.
May 26, 2022 · Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects.
Cala is a leading developer of desirable new homes and sustainable communities across the South of England, the. Midlands and Scotland. We are a highly ...
Find the latest Calithera Biosciences, Inc. (CALA) stock quote, history, news and other vital information to help you with your stock trading and investing.
Missing: relations | Show results with:relations
Maria F. Cala · Experienced financial professional with ability to form partnerships and drive change and simplification · View mutual connections with Maria F.
Discover real-time Calithera Biosciences Inc. (CALA) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions ...